Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat
- PMID: 10930897
- DOI: 10.1046/j.1365-2036.2000.00796.x
Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat
Abstract
Background: hTFF2 and pTFF2 (formerly PSP and hSP, respectively) are members of the trefoil factor family (TFF) and are distributed throughout the gastrointestinal tract in both normal and diseased tissue. Trefoil factors have been shown to exert a mucosal protectant and/or healing role in a number of animal models but controversy exists surrounding this property in relation to their dose and route of administration.
Aim: To investigate the effects of topically applied and intravenously infused trefoil factors (hTFF2 and pTFF2) and prostaglandin E2 on ethanol-induced gastric mucosal damage in rats.
Method: A gastric chamber preparation in the anaesthetized rat was used. Injury was caused by exposing the gastric mucosa to absolute ethanol for 1 min. Trefoil factors or prostaglandin E2 were administered either intravenously or topically before and after the introduction of absolute ethanol onto the gastric mucosa. Damage was assessed by measurement of gastric mucosal Na+ leakage and area of macroscopic injury.
Results: Like prostaglandin E2, intravenous administration of hTFF2 and pTFF2 reduced both the gastric mucosal Na+ leakage and the mean area of damage caused by ethanol. Similarly, treatment of the gastric mucosa with topical application of hTFF2 at doses of 120 microg/kg and above reduced the Na+ leakage and the area of damage. pTFF2 at 120 microg/kg and 1.2 mg/kg applied topically produced a marked reduction in total area of damage.
Conclusion: Intravenously infused hTFF2 and pTFF2 protect the gastric mucosa from ethanol-induced damage in the anaesthetized rat. In addition, topical application of trefoil factors also was effective at protecting the gastric mucosa from injury at doses lower than previously reported.
Similar articles
-
Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.Gastroenterology. 1996 Feb;110(2):489-97. doi: 10.1053/gast.1996.v110.pm8566596. Gastroenterology. 1996. PMID: 8566596
-
Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat.Gut. 1999 Oct;45(4):516-22. doi: 10.1136/gut.45.4.516. Gut. 1999. PMID: 10486358 Free PMC article.
-
Trefoil peptides: a novel modality to prevent gastric injury?Gastroenterology. 1996 Feb;110(2):632-5. doi: 10.1053/gast.1996.v110.agast960632. Gastroenterology. 1996. PMID: 8566614 No abstract available.
-
Trefoil peptides: what are they and what do they do?J R Coll Physicians Lond. 1997 Jan-Feb;31(1):37-41. J R Coll Physicians Lond. 1997. PMID: 9044196 Free PMC article. Review.
-
Trefoil peptides: mitogens, motogens, or mirages?J Clin Gastroenterol. 1997;25 Suppl 1:S94-100. doi: 10.1097/00004836-199700001-00016. J Clin Gastroenterol. 1997. PMID: 9479633 Review.
Cited by
-
Gut homeostasis, injury, and healing: New therapeutic targets.World J Gastroenterol. 2022 May 7;28(17):1725-1750. doi: 10.3748/wjg.v28.i17.1725. World J Gastroenterol. 2022. PMID: 35633906 Free PMC article. Review.
-
Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa.Histochem Cell Biol. 2006 Nov;126(5):617-25. doi: 10.1007/s00418-006-0197-y. Epub 2006 Jun 20. Histochem Cell Biol. 2006. PMID: 16786324
-
Selective reduction of intestinal trefoil factor in untreated coeliac disease.Clin Exp Immunol. 2002 Dec;130(3):526-31. doi: 10.1046/j.1365-2249.2002.02011.x. Clin Exp Immunol. 2002. PMID: 12452845 Free PMC article.
-
The Role of Mucins in Cancer and Cancer Progression: A Comprehensive Review.Curr Issues Mol Biol. 2025 May 29;47(6):406. doi: 10.3390/cimb47060406. Curr Issues Mol Biol. 2025. PMID: 40699805 Free PMC article. Review.
-
Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing.Br J Pharmacol. 2009 Jan;156(2):262-72. doi: 10.1111/j.1476-5381.2008.00044.x. Epub 2008 Dec 9. Br J Pharmacol. 2009. PMID: 19076725 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous